Publications and Books

Full Peer Reviewed Publications(97)

Philipose Z, Mendall MA Obesity, old age and frailty are the true risk factors for COVID-19 mortality and not chronic disease or ethnicity  doi:

Mendall M, Jensen CB, Ängquist LH, Baker JL, Jess T. Childhood growth and risk of inflammatory bowel disease: a population-based study of 317,030 children. Scand J Gastroenterol. 2019 Jul;54(7):863-868. doi: 10.1080/00365521.2019.1635201. Epub 2019 Jul 11. PMID: 31294613.

Mendall MA, Jensen CB, Sørensen TIA, Ängquist LH, Jess T. Body mass index in young men and risk of inflammatory bowel disease through adult life: A population-based Danish cohort study. Sci Rep. 2019 Apr 23;9(1):6360. doi: 10.1038/s41598-019-42642-8. PMID: 31015530; PMCID: PMC6478722.

Jankowski JAZ, de Caestecker J, Love SB, Reilly G, Watson P, Sanders S, Ang Y, Morris D, Bhandari P, Brooks C, Attwood S, Harrison R, Barr H, Moayyedi P; AspECT Trial Team. Esomeprazole and aspirin in Barrett's oesophagus (AspECT): a randomised factorial trial. Lancet. 2018 Aug 4;392(10145):400-408. doi: 10.1016/S0140-6736(18)31388-6. Epub 2018 Jul 26. Erratum in: Lancet. 2018 Dec 15;392(10164):2552. PMID: 30057104; PMCID: PMC6083438.

Carbone M, Nardi A, Flack S, Carpino G, Varvaropoulou N, Gavrila C, Spicer A, Badrock J, Bernuzzi F, Cardinale V, Ainsworth HF, Heneghan MA, Thorburn D, Bathgate A, Jones R, Neuberger JM, Battezzati PM, Zuin M, Taylor-Robinson S, Donato MF, Kirby J, Mitchell-Thain R, Floreani A, Sampaziotis F, Muratori L, Alvaro D, Marzioni M, Miele L, Marra F, Giannini E, Gaudio E, Ronca V, Bonato G, Cristoferi L, Malinverno F, Gerussi A, Stocken DD, Cordell HJ, Hirschfield GM, Alexander GJ, Sandford RN, Jones DE, Invernizzi P, Mells GF; Italian PBC Study Group and the UK–PBC Consortium. Pretreatment prediction of response to ursodeoxycholic acid in primary biliary cholangitis: development and validation of the UDCA Response Score. Lancet Gastroenterol Hepatol. 2018 Sep;3(9):626-634. doi: 10.1016/S2468-1253(18)30163-8. Epub 2018 Jul 13. PMID: 30017646; PMCID: PMC6962055.

Bjorn-Jensen C, Ängquist LA, Mendall MA et al. Childhood body mass index and risk of inflammatory bowel disease in adulthood: A population based cohort study. Am J Gastroenterol. 2018 Mar 13. doi: 10.1038/s41395-018-0031-x. [Epub ahead of print

Mendall M, Harpsøe MC, Kumar D, Andersson M, Jess Relation of body mass index to risk of developing inflammatory bowel disease amongst women in the Danish National Birth Cohort.
PLoS One. 2018 Jan 24;13(1)

Sturm A, Maaser C, Mendall M, Karagiannis D, Karatzas P, Ipenburg N, Sebastian S, Rizzello F, Limdi J, Katsanos K, Schmidt C, Jeuring S, Colombo F, Gionchetti P.
European Crohn's and Colitis Organisation Topical Review on IBD in the Elderly.  Crohns Colitis. 2017 Mar 1;11(3):263-273. doi: 10.1093/ecco-jcc/jjw188. Epub 2016 Oct 20


Mendall MA, Chan D, Patel R, Kumar D Faecal calprotectin: factors affecting levels and its potential role as a surrogate marker for risk of development of Crohn's Disease. BMC Gastroenterol. 2016 Oct 7;16(1):126.

Treatment of Crohn's Disease with an IgG4-Guided Exclusion Diet: A Randomized Controlled Trial.Gunasekeera V, Mendall MA, Chan D, Kumar D.
Dig Dis Sci. 2016 Apr;61(4):1148-57. doi: 10.1007/s10620-015-3987-z. Epub 2016 Jan 25.

International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways. Cordell HJ, Han Y, Mells GF, Li Y, Hirschfield GM, Greene CS, Xie G, Juran BD, Zhu D, Qian DC, Floyd JA, Morley KI, Prati D, Lleo A, Cusi D; Canadian-US PBC Consortium; Italian PBC Genetics Study Group; UK-PBC Consortium, Gershwin ME, Anderson CA, Lazaridis KN, Invernizzi P, Seldin MF, Sandford RN, Amos CI, Siminovitch KA. Nat Commun. 2015 Sep 22;6:8019.

What is known about the mechanisms of dietary influences in Crohn's disease?
Chan D, Kumar D, Mendall M.Nutrition. 2015 Oct;31(10):1195-203. doi: 10.1016/j.nut.2015.04.018. Epub 2015 May 15. Review.

The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cirrhosis.
Carbone M, Sharp SJ, Flack S, Paximadas D, Spiess K, Adgey C, Griffiths L, Lim R, Trembling P, Williamson K, Wareham NJ, Aldersley M, Bathgate A, Burroughs AK, Heneghan MA, Neuberger JM, Thorburn D, Hirschfield GM, Cordell HJ, Alexander GJ, Jones DE, Sandford RN, Mells GF; and the members of the UK-PBC Consortium.Hepatology. 2015 Jul 29. doi: 10.1002/hep.28017. [Epub ahead of print]

Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.Mendall M, Chan D, Kumar D.
Inflamm Bowel Dis. 2015 Aug;21(8):E17-8. doi: 10.1097/MIB.0000000000000494.

Barrett's Oesophagus Surveillance versus endoscopy at need Study (BOSS): protocol and analysis plan for a multicentre randomized controlled trial.
Old O, Moayyedi P, Love S, Roberts C, Hapeshi J, Foy C, Stokes C, Briggs A, Jankowski J, Barr H; BOSS Trial Team. J Med Screen. 2015 Sep;22(3):158-64. doi: 10.1177/0969141315575052. Epub 2015 Mar 12.

Determinants of Weight Loss prior to Diagnosis in Inflammatory Bowel Disease: A Retrospective Observational Study.
Elsherif Y, Alexakis C, Mendall M.
Gastroenterol Res Pract. 2014;2014:762191. doi: 10.1155/2014/762191. Epub 2014 Nov 23..

Diverticular Disease and Vascular Diseases: A Shared Responsiveness to Injury Is Likely to Be the Underlying Mechanism. Mendall MA. Clin Gastroenterol Hepatol. 2015 Jul;13(7):1375. doi: 10.1016/j.cgh.2014.12.004. Epub 2014 Dec 10.

.Environment and risk of Crohn's disease: comments on "the increasing weight of Crohn's disease subjects in clinical trials".
Mendall MA.
Inflamm Bowel Dis. 2014 Apr;20(4):E11-2. doi: 10.1097/MIB.0000000000000005.
Advanced age influences the dynamic changes in circulating C-reactive protein following injury.
Pinato DJ, Bains J, Irkulla S, Pomroy J, Ujam B, Gaze D, Mendall MA.
J Clin Pathol. 2013 Aug;66(8):695-9. doi: 10.1136/jclinpath-2012-201374. Epub 2013 Mar 28.

Abdominal adiposity is the main determinant of the C-reactive response to injury in subjects undergoing inguinal hernia repair.
Irkulla S, Ujam B, Gaze D, Kumar D, Mendall MA.
J Inflamm (Lond). 2013 Feb 7;10(1):5. doi: 10.1186/1476-9255-10-5.

Ethnicity in relation to incidence of oesophageal and gastric cancer in England.
Coupland VH, Lagergren J, Konfortion J, Allum W, Mendall MA, Hardwick RH, Linklater KM, Møller H, Jack RH.
Br J Cancer. 2012 Nov 20;107(11):1908-14. doi: 10.1038/bjc.2012.465. Epub 2012 Oct 11.

Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study. Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA.BMC Cancer. 2012 Jan 12;12:11. doi: 10.1186/1471-2407-12-11.

Pancreatic cystic neoplasm presenting as a large gastric ulcer.
Mathew S, Gupta S, Mendall M, Sarma D.
Endoscopy. 2011;43 Suppl 2 UCTN:E363. doi: 10.1055/s-0030-1256644. Epub 2011

Is obesity a risk factor for Crohn's disease?
Mendall MA, Gunasekera AV, John BJ, Kumar D.
Dig Dis Sci. 2011 Mar;56(3):837-44. doi: 10.1007/s10620-010-1541-6. Epub 2011 Jan 8.

Do guidelines improve clinical practice? - a national survey on surveillance colonoscopies.
John BJ, Irukulla S, Mendall MA, Abulafi AM.
Colorectal Dis. 2010 Jul;12(7):642-5. doi: 10.1111/j.1463-1318.2009.01869.x. Epub 2009 Apr 10.

Chronic subclinical bowel inflammation may explain increased risk of colorectal cancer in obese people.
John BJ, Abulafi AM, Poullis A, Mendall MA.
Gut. 2007 Jul;56(7):1034-5.

Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome.
Davis K, Philpott S, Kumar D, Mendall M.
Int J Clin Pract. 2006 Sep;60(9):1080-6. Epub 2006 Jun 2

John BJ, Irukulla S, Abulafi AM, Kumar D, Mendall MA. Systematic review: adipose tissue, obesity and gastrointestinal diseases. Aliment Pharmacol Ther. 2006 Jun 1;23(11):1511-23.

Davis K, Philpott S, Kumar D, Mendall M. Randomised double-blind placebo-controlled trial of aloe vera for irritable bowel syndrome. Int J Clin Pract. 2006 Sep;60(9):1080-6. Epub 2006 Jun 2

Poullis A, Foster R, Shetty A, Fagerhol MK, Mendall MA.Bowel inflammation as measured by fecal calprotectin: a link between lifestyle factors and colorectal cancer risk. Cancer Epidemiol Biomarkers Prev. 2004 Feb;13(2):279-84.

Poullis AP, Shetty AK, Risley PD, Collinson PO, Mendall MA. Effect of the CD14 promoter polymorphism on liver function tests and its association with alcohol and obesity. Eur J Gastroenterol Hepatol. 2003 Dec;15(12):1317-22.

Poullis A, Foster R, Mendall MA, Fagerhol MK. Emerging role of calprotectin in gastroenterology. J Gastroenterol Hepatol. 2003 Jul;18(7):756-62.

Poullis A, Foster R, Mendall MA, Shreeve D, Wiener K. Proton pump inhibitors are associated with elevation of faecal calprotectin and may affect specificity.
Eur J Gastroenterol Hepatol. 2003 May;15(5):573-4; author reply 574.

Mayr M, Kiechl S, Mendall MA, Willeit J, Wick G, Xu Q. Increased risk of atherosclerosis is confined to CagA-positive Helicobacter pylori strains: prospective results from the Bruneck study.Stroke. 2003 Mar;34(3):610-5. Epub 2003 Feb 13.

Stone AF, Mendall MA, Kaski JC, Edger TM, Risley P, Poloniecki J, Camm AJ, Northfield TC. Effect of treatment for Chlamydia pneumoniae and Helicobacter pylori on markers of inflammation and cardiac events in patients with acute coronary syndromes: South Thames Trial of Antibiotics in Myocardial Infarction and Unstable Angina (STAMINA).Circulation. 2002 Sep 3;106(10):1219-23.

Sitzer M, Markus HS, Mendall MA, Liehr R, Knorr U, Steinmetz H. C-reactive protein and carotid intimal medial thickness in a community population. J Cardiovasc Risk. 2002 Apr;9(2):97-103

Markus HS, Risley P, Mendall MA, Steinmetz H, Sitzer M. Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness.
J Cardiovasc Risk. 2002 Feb;9(1):1-6.

Poullis AP, Zar S, Sundaram KK, Moodie SJ, Risley P, Theodossi A, Mendall MA. A new, highly sensitive assay for C-reactive protein can aid the differentiation of inflammatory bowel disorders from constipation- and diarrhoea-predominant functional bowel disorders.Eur J Gastroenterol Hepatol. 2002 Apr;14(4):409-12.

Poullis A, Foster R, Northfield TC, Mendall MA. Review article: faecal markers in the assessment of activity in inflammatory bowel disease. Aliment Pharmacol Ther. 2002 Apr;16(4):675-81

Maxwell PR, Rink E, Kumar D, Mendall MA. Antibiotics increase functional abdominal symptoms. Am J Gastroenterol. 2002 Jan;97(1):104-8.

Markus H, Kapozsta Z, Ditrich R, Wolfe C, Ali N, Powell J, Mendall M, Cullinane M. Increased common carotid intima-media thickness in UK African Caribbeans and its relation to chronic inflammation and vascular candidate gene polymorphisms.
Stroke. 2001 Nov;32(11):2465-71.

Stone AF, Risley P, Markus HS, Butland BK, Strachan DP, Elwood PC, Mendall MA. Ischaemic heart disease and Cag A strains of Helicobacter pylori in the Caerphilly heart disease study. Heart. 2001 Nov;86(5):506-9.

Poullis A, Mendall MA. Alcohol, obesity, and TNF-alpha. Gut. 2001 Aug;49(2):313-4.

Shetty A, Mendall M. Diagnosing gastroenteritis and travellers' diarrhoea.
Practitioner. 2001 Mar;245(1620):192-4, 199-200, 204.

Sundaram KK, Mendall MA. Lymphocytic gastritis and Helicobacter pylori: reluctant mucosal partners? Helicobacter. 2000 Dec;5(4):248-9

 Mendall MA, Strachan DP, Butland BK, Ballam L, Morris J, Sweetnam PM, Elwood PC. C-reactive protein: relation to total mortality, cardiovascular mortality and cardiovascular risk factors in men.Eur Heart J. 2000 Oct;21(19):1584-90.

Stone AF, Mendall MA. Helicobacter pylori is an aetiological factor for ischaemic heart disease: the case in favour. Dig Liver Dis. 2000 Jan-Feb;32(1):62-4.

Ballam LD, Mendall MA, Asante M, Morris J, Strachan DP, Whincup PH, Cook DG. Western blotting is useful in the salivary diagnosis of Helicobacter pylori infection. J Clin Pathol. 2000 Apr;53(4):314-7. Erratum in: J Clin Pathol 2000 Sep;53(9):725.

Cook DG, Mendall MA, Whincup PH, Carey IM, Ballam L, Morris JE, Miller GJ, Strachan DP. C-reactive protein concentration in children: relationship to adiposity and other cardiovascular risk factors. Atherosclerosis. 2000 Mar;149(1):139-50.

Strachan DP, Carrington D, Mendall M, Butland BK, Yarnell JW, Elwood P. Chlamydia pneumoniae serology, lung function decline, and treatment for respiratory disease. Am J Respir Crit Care Med. 2000 Feb;161(2 Pt 1):493-7.

Asante MA, Mendall MA, Ballam L, Morris J, Northfield TC. Relationship between Helicobacter pylori, gastric parietal cell antibodies and heat shock proteins. Eur J Gastroenterol Hepatol. 1999 Dec;11(12):1365-70.

Asante M, Lord J, Mendall M, Northfield T. Endoscopy for Helicobacter pylori sero-negative young dyspeptic patients: an economic evaluation based on a randomized trial. Eur J Gastroenterol Hepatol. 1999 Aug;11(8):851-6.

Markus HS, Sitzer M, Carrington D, Mendall MA, Steinmetz H. Chlamydia pneumoniae infection and early asymptomatic carotid atherosclerosis. Circulation. 1999 Aug 24;100(8):832-7.

Strachan DP, Carrington D, Mendall MA, Ballam L, Morris J, Butland BK, Sweetnam PM, Elwood PC. Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study. BMJ. 1999 Apr 17;318(7190):1035-9.

 Strachan DP, Carrington D, Mendall MA, Butland BK, Sweetnam PM, Elwood PC. Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study. Heart. 1999 Mar;81(3):248-51.

Asante MA, Mendall M, Patel P, Ballam L, Northfield TC. A randomized trial of endoscopy vs no endoscopy in the management of seronegative Helicobacter pylori dyspepsia. Eur J Gastroenterol Hepatol. 1998 Dec;10(12):983-9

Asante MA, Mendall MA, Bland JM, Northfield TC. Determinants of prescribing costs for ulcer-healing drugs and upper gastrointestinal endoscopy in general practice. Eur J Gastroenterol Hepatol. 1998 Jul;10(7):589-93.

Asante MA, Mendall MA, Finlayson C, Ballam L, Northfield T. Screening dyspeptic patients for Helicobacter pylori prior to endoscopy: laboratory or near-patient testing? Eur J Gastroenterol Hepatol. 1998 Oct;10(10):843-6.

Strachan DP, Mendall MA, Carrington D, Butland BK, Yarnell JW, Sweetnam PM, Elwood PC. Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the Caerphilly prospective heart disease study. Circulation. 1998 Sep 29;98(13):1286-90

Sundaram KK, Mendall MA. Helicobacter pylori and hepatitis A: a common route but uncommon mode of infection? Helicobacter. 1998 Jun;3(2):140-1.

Zar S, Mendall MA. Clinical practice--strategies for management of dyspepsia.
Br Med Bull. 1998;54(1):217-28.

Asante MA, Mendall MA, Northfield TC. Which Helicobacter pylori-positive dyspeptics are likely to respond symptomatically to empirical H. pylori eradication? Eur J Gastroenterol Hepatol. 1998 Mar;10(3):265-8.

Mendall MA. Inflammatory responses and coronary heart disease. BMJ. 1998 Mar 28;316(7136):953-4.

Asante MA, Patel P, Mendall M, Jazrawi R, Northfield TC. The impact of direct access endoscopy, Helicobacter pylori near patient testing and acid suppressants on the management of dyspepsia in general practice. Int J Clin Pract. 1997 Nov-Dec;51(8):497-9.

Mendall MA. C-reactive protein response and progression of atherosclerosis: is atherosclerosis the byproduct of systemic infection? Cardiologia. 1997 Nov;42(11):1139-44.

Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol. 1998 Jan;10(1):59-62.

Mendall MA. Serology for diagnosis of Helicobacter pylori infection. Helicobacter. 1997 Mar;2(1):54-5.

Markus HS, Mendall MA. Helicobacter pylori infection: a risk factor for ischaemic cerebrovascular disease and carotid atheroma. J Neurol Neurosurg Psychiatry. 1998 Jan;64(1):104-7.

Saxena V, Markus H, Swaminathan S, Mendall MA Hyperhomocysteinaemia, Helicobacter pylori, and coronary heart disease. Heart. 1997 Nov;78(5):524.

Maxwell PR, Mendall MA, Kumar D. Irritable bowel syndrome. Lancet. 1997 Dec 6;350(9092):1691-5

Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, Camm AJ, Northfield TC. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997 Sep;78(3):273-7.

Asante M, Ahmed H, Patel P, Davis T, Finlayson C, Mendall M, Northfield T. Gastric mucosal hydrophobicity in duodenal ulceration: role of Helicobacter pylori infection density and mucus lipids. Gastroenterology. 1997 Aug;113(2):449-54

Gupta S, Leatham EW, Carrington D, Mendall MA, Kaski JC, Camm AJ. Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. Circulation. 1997 Jul 15;96(2):404-7.

Mendall MA. Transmission of Helicobacter pylori. Semin Gastrointest Dis. 1997 Jul;8(3):113-23.

Maxwell P, Mendall M. Prevalence of gastrointestinal symptoms after bacterial gastroenteritis. Patients with the irritable bowel syndrome may underreport historical symptoms. BMJ. 1997 Jun 28;314(7098):1902-3.

Wincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease and stroke in middle-aged men. Heart. 1997 Mar;77(3):294

Goodwin CS, Mendall MM, Northfield TC. Helicobacter pylori infection. Lancet. 1997 Jan 25;349(9047):265-9.

Whincup PH, Mendall MA, Perry IJ, Strachan DP, Walker M. Prospective relations between Helicobacter pylori infection, coronary heart disease, and stroke in middle aged men. Heart. 1996 Jun;75(6):568-72

Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996 Apr 27;312(7038):1061-5.

Khulusi S, Badve S, Patel P, Lloyd R, Marrero JM, Finlayson C, Mendall MA, Northfield TC. Pathogenesis of gastric metaplasia of the human duodenum: role of Helicobacter pylori, gastric acid, and ulceration. Gastroenterology. 1996 Feb;110(2):452-8.

Patel P, Khulusi S, Mendall MA, Lloyd R, Jazrawi R, Maxwell JD, Northfield TC. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet. 1995 Nov 18;346(8986):1315-8.

Patel P, Mendall MA, Carrington D, Strachan DP, Leatham E, Molineaux N, Levy J, Blakeston C, Seymour CA, Camm AJ, et al. Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors. BMJ. 1995 Sep 16;311(7007):711-4.

Khulusi S, Mendall MA, Patel P, Levy J, Badve S, Northfield TC. Helicobacter pylori infection density and gastric inflammation in duodenal ulcer and non-ulcer subjects. Gut. 1995 Sep;37(3):319-24

Khulusi S, Hanby AM, Marrero JM, Patel P, Mendall MA, Badve S, Poulsom R, Elia G, Wright NA, Northfield TC. Expression of trefoil peptides pS2 and human spasmolytic polypeptide in gastric metaplasia at the margin of duodenal ulcers. Gut. 1995 Aug;37(2):205-9.

Mendall MA, Northfield TC. Transmission of Helicobacter pylori infection. Gut. 1995 Jul;37(1):1-3

Khulusi S, Ahmed HA, Patel P, Mendall MA, Northfield TC. The effects of unsaturated fatty acids on Helicobacter pylori in vitro. J Med Microbiol. 1995 Apr;42(4):276-82.

Mendall MA, Jazrawi RP, Marrero JM, Molineaux N, Levi J, Maxwell JD, Northfield TC. Serology for Helicobacter pylori compared with symptom questionnaires in screening before direct access endoscopy. Gut. 1995 Mar;36(3):330-3.

Mendall MA, Carrington D, Strachan D, Patel P, Molineaux N, Levi J, Toosey T, Camm AJ, Northfield TC. Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. J Infect. 1995 Mar;30(2):121-8.

Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northfield TC. Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut. 1995 Feb;36(2):193-7.

Khulusi S, Mendall MA, Badve S, Patel P, Finlayson C, Northfield TC. Effect of Helicobacter pylori eradication on gastric metaplasia of the duodenum. Gut. 1995 Feb;36(2):193-7. Erratum in: Gut 1995 Aug;37(2):300.

Patel P, Mendall MA, Khulusi S, Northfield TC, Strachan DP. Helicobacter pylori infection in childhood: risk factors and effect on growth. BMJ. 1994 Oct 29;309(6962):1119-23.

Patel P, Mendall MA, Khulusi S, Molineaux N, Levy J, Maxwell JD, Northfield TC. Salivary antibodies to Helicobacter pylori: screening dyspeptic patients before endoscopy. Lancet. 1994 Aug 20;344(8921):511-2

Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet. 1994 Jun 25;343(8913):1634-5

Patel P, Carrington D, Strachan DP, Leatham E, Goggin P, Northfield TC, Mendall MA. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet. 1994 Jun 25;343(8913):1634-5

Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Camm AJ, Northfield TC. Relation of Helicobacter pylori infection and coronary heart disease. Br Heart J. 1994 May;71(5):437-9.

P. Patel, M. Mendall, S. Khulusi, N. Molineaux, J. Levy, J. Maxwell, T.C. Northfield. A new model for the management of dyspepsia. Theoretical surgery  1993; 8: 227-229.

Mendall M, Goggin P, Marrero J, Molineaux N, Levy J, Badve S, Corbishley C, Finlayson C, Maxwell J, Northfield T. Helicobacter pylori screening prior to endoscopy. Eur J Gastroenterol Hepatol 1992;4:713-717

Mendall MA, Goggin PM, Molineaux N, Levy J, Toosy T, Strachan D, Northfield TC. Childhood living conditions and Helicobacter pylori seropositivity in adult life. Lancet. 1992 Apr 11;339(8798):896-7.

Make An Enquiry